Mobile website
Archive > Volume 28 Issue 4 > 2021,28(4):416-418. DOI:10.3872/j.issn.1007-385X.2021.04.016 Prev Next
Carrizumab plus nab-paclitaxel as second-line treatment stage Ⅳ lung large-cell neuroendocrine carcinoma: A case report and literature review
- Article
- Figures
- Metrics
- Preview PDF
- Reference
- Related
- Cited by
- Materials
Abstract:
Keywords:
Project Supported:
Project supported by the Training Project of New Talents in Medicine of Zhejiang Provence (No. Zhe wei fa[2015]70)
Clc Number:
